Hopman Mark
SEC CIK 2048497 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBNX | Beta Bionics, Inc. | Chief Commercial Off | 56.5K | — | $2.94M | 19 | 2025-02-27 | 2026-09-16 |
Most active insiders at BBNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hopman Mark | Chief Commercial Off | — | $2.27M |
| 2 | Feider Stephen | CFO | — | $1.62M |
| 3 | Saint Sean | Pres, CEO, Dir | — | $786.3K |
| 4 | Mensinger Mike | Chief Product Off | — | $538.6K |
| 5 | Jones Christy | Dir | — | $228.2K |
| 6 | Russell Steven Jon | Chief Medical Off | — | $176.7K |
| 7 | Lezack Adam | Dir | — | $100.5K |
| 8 | Palasis Maria | Dir | — | $79.4K |
| 9 | Dearen Danny L. | Dir | — | — |
| 10 | CARNEY SEAN | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2026-09-18 19:51 | 2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $18.46 | -36.0K | 88.0K | -29% | -$664.6K |
| T | 2026-09-17 16:15 | 2026-09-16 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $20.13 | -30.8K | 56.5K | -35% | -$619.6K |
| T | 2026-09-15 16:15 | 2026-09-14 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $15.52 | -775 | 86.4K | -0.9% | -$12.0K |
| T | 2026-09-10 16:30 | 2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $18.46 | -36.9K | 87.2K | -30% | -$680.7K |
| 2026-09-03 18:15 | 2026-09-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $19.11 | -5,327 | 124.0K | -4% | -$101.8K | |
| T | 2026-06-25 16:34 | 2026-06-24 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $15.01 | -1,258 | 129.4K | -1.0% | -$18.9K |
| T | 2026-06-05 18:05 | 2026-06-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $12.31 | -275 | 130.6K | -0.2% | -$3,385 |
| 2026-06-03 18:00 | 2026-06-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $12.61 | -5,329 | 130.9K | -4% | -$67.2K | |
| M | 2026-03-16 | 2025-12-02+ | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $30.27 | -2,917 | 136.2K | -2% | -$88.3K |
| 2026-03-05 | 2026-03-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $11.57 | -353 | 139.1K | -0.3% | -$4,084 | |
| D | 2026-03-03 | 2026-02-27 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | A - Grant | $0.00 | +109.1K | 140.3K | +350% | $0 |
| D | 2026-03-03 | 2026-03-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $12.36 | -834 | 139.5K | -0.6% | -$10.3K |
| DM | 2025-09-08 | 2025-09-04+ | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | M - OptEx | $5.10 | +16.2K | 33.9K | +91% | +$82.4K |
| DM | 2025-09-08 | 2025-09-04+ | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale+OE | $20.34 | -18.2K | 31.2K | -37% | -$370.8K |
| 2025-09-04 | 2025-09-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $18.86 | -848 | 33.3K | -2% | -$16.0K | |
| D | 2025-08-20 | 2025-08-19 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale+OE | $16.61 | -16.2K | 34.1K | -32% | -$268.4K |
| D | 2025-08-20 | 2025-08-19 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | M - OptEx | $5.10 | +16.2K | 50.3K | +47% | +$82.4K |
| M | 2025-06-04 | 2025-06-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | S - Sale | $17.89 | -868 | 34.2K | -2% | -$15.5K |
| D | 2025-03-03 | 2025-02-27 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Off | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations